Concepts (73)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Transcriptome | 4 | 2024 | 630 | 1.490 |
Why?
|
| Breast Neoplasms | 7 | 2024 | 3011 | 1.460 |
Why?
|
| Genome-Wide Association Study | 7 | 2024 | 1671 | 1.420 |
Why?
|
| Genetic Predisposition to Disease | 8 | 2024 | 2340 | 1.070 |
Why?
|
| RNA Splicing | 1 | 2024 | 152 | 0.840 |
Why?
|
| Quantitative Trait Loci | 4 | 2024 | 608 | 0.660 |
Why?
|
| Haptoglobins | 1 | 2017 | 9 | 0.600 |
Why?
|
| Estrogen Receptor alpha | 1 | 2017 | 148 | 0.540 |
Why?
|
| Nuclear Proteins | 2 | 2017 | 726 | 0.520 |
Why?
|
| Polymorphism, Single Nucleotide | 6 | 2024 | 2401 | 0.420 |
Why?
|
| Introns | 2 | 2024 | 299 | 0.260 |
Why?
|
| Receptors, Estrogen | 2 | 2024 | 393 | 0.230 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2024 | 1265 | 0.230 |
Why?
|
| Female | 11 | 2024 | 46200 | 0.220 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2023 | 112 | 0.190 |
Why?
|
| Gene Expression Profiling | 2 | 2024 | 1431 | 0.190 |
Why?
|
| Anemia, Aplastic | 1 | 2021 | 32 | 0.190 |
Why?
|
| Multifactorial Inheritance | 1 | 2022 | 169 | 0.180 |
Why?
|
| Graft vs Host Disease | 1 | 2023 | 360 | 0.180 |
Why?
|
| Hypertension, Renal | 1 | 2020 | 19 | 0.180 |
Why?
|
| Humans | 14 | 2024 | 89349 | 0.170 |
Why?
|
| Aspirin | 1 | 2021 | 159 | 0.170 |
Why?
|
| Hematologic Neoplasms | 1 | 2023 | 343 | 0.160 |
Why?
|
| Pelvic Organ Prolapse | 1 | 2021 | 154 | 0.160 |
Why?
|
| Germ-Line Mutation | 1 | 2021 | 344 | 0.150 |
Why?
|
| Antihypertensive Agents | 1 | 2020 | 249 | 0.150 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2021 | 358 | 0.150 |
Why?
|
| Pancreatic Neoplasms | 1 | 2023 | 669 | 0.140 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2020 | 219 | 0.140 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2016 | 25 | 0.140 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2023 | 890 | 0.130 |
Why?
|
| Blood Pressure | 1 | 2020 | 900 | 0.130 |
Why?
|
| Sleep | 1 | 2020 | 452 | 0.130 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2016 | 161 | 0.130 |
Why?
|
| Risk Factors | 2 | 2022 | 5498 | 0.120 |
Why?
|
| Biomarkers | 1 | 2021 | 1767 | 0.120 |
Why?
|
| Crohn Disease | 1 | 2021 | 762 | 0.120 |
Why?
|
| Colitis, Ulcerative | 1 | 2021 | 739 | 0.110 |
Why?
|
| Cell Cycle Proteins | 1 | 2016 | 401 | 0.110 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2016 | 1096 | 0.080 |
Why?
|
| Head and Neck Neoplasms | 1 | 2016 | 1063 | 0.080 |
Why?
|
| Estrogens | 1 | 2024 | 201 | 0.050 |
Why?
|
| Australia | 1 | 2023 | 101 | 0.050 |
Why?
|
| Cyclophosphamide | 1 | 2023 | 302 | 0.050 |
Why?
|
| Point-of-Care Systems | 1 | 2023 | 148 | 0.050 |
Why?
|
| Tertiary Care Centers | 1 | 2021 | 106 | 0.040 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 2020 | 29 | 0.040 |
Why?
|
| Drug Resistance | 1 | 2020 | 232 | 0.040 |
Why?
|
| Uterus | 1 | 2021 | 222 | 0.040 |
Why?
|
| Genetic Testing | 1 | 2023 | 537 | 0.040 |
Why?
|
| Adult | 3 | 2023 | 26607 | 0.040 |
Why?
|
| Body Mass Index | 1 | 2021 | 773 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2020 | 871 | 0.040 |
Why?
|
| Prevalence | 1 | 2021 | 1243 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2021 | 9057 | 0.040 |
Why?
|
| Tissue Array Analysis | 1 | 2016 | 127 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2016 | 136 | 0.030 |
Why?
|
| Biomarkers, Tumor | 1 | 2024 | 1549 | 0.030 |
Why?
|
| Genetic Vectors | 1 | 2016 | 446 | 0.030 |
Why?
|
| Cell Cycle | 1 | 2016 | 509 | 0.030 |
Why?
|
| Male | 3 | 2023 | 42410 | 0.030 |
Why?
|
| Histones | 1 | 2016 | 329 | 0.030 |
Why?
|
| Aged | 2 | 2023 | 19165 | 0.030 |
Why?
|
| Cell Survival | 1 | 2016 | 983 | 0.030 |
Why?
|
| Prognosis | 1 | 2021 | 3783 | 0.030 |
Why?
|
| Smoking | 1 | 2016 | 621 | 0.030 |
Why?
|
| DNA Methylation | 1 | 2016 | 657 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2020 | 4289 | 0.020 |
Why?
|
| Middle Aged | 2 | 2021 | 25974 | 0.020 |
Why?
|
| Time Factors | 1 | 2020 | 5337 | 0.020 |
Why?
|
| Young Adult | 1 | 2021 | 6312 | 0.020 |
Why?
|
| Adolescent | 1 | 2021 | 9263 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2020 | 8241 | 0.020 |
Why?
|